Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Seres Therapeutics Inc (MCRB)

Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Seres Therapeutics: Q3 Earnings Snapshot AP - Thu Nov 2, 2023

Seres Therapeutics: Q3 Earnings Snapshot

MCRB : 0.5765 (-1.32%)
Flagship Pioneering Announces the Merger of Two Leading Programmable Medicine Platforms to Form Sail Biomedicines PR Newswire - Thu Oct 19, 2023

/PRNewswire/ -- Flagship Pioneering today announced the combination of Laronde and Senda Biosciences to launch Sail Biomedicines, a company pioneering the...

DNLI : 16.20 (-2.41%)
FHTX : 5.61 (+1.45%)
MRNA : 101.99 (-0.01%)
OMGA : 2.40 (-0.83%)
SANA : 7.70 (-0.39%)
MCRB : 0.5765 (-1.32%)
Flagship Pioneering Appoints John Lepore as CEO-Partner and CEO of ProFound Therapeutics PR Newswire - Mon Oct 2, 2023

/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, and ProFound™ Therapeutics, a company pioneering the discovery of a vastly expanded...

DNLI : 16.20 (-2.41%)
FHTX : 5.61 (+1.45%)
MRNA : 101.99 (-0.01%)
OMGA : 2.40 (-0.83%)
SANA : 7.70 (-0.39%)
MCRB : 0.5765 (-1.32%)
Flagship Pioneering Named to Fortune's 2023 "Change the World" List PR Newswire - Wed Sep 27, 2023

/PRNewswire/ -- Flagship Pioneering today announced it has been named to FORTUNE's 2023 "Change the World" list, an annual global ranking of companies that...

DNLI : 16.20 (-2.41%)
FHTX : 5.61 (+1.45%)
MRNA : 101.99 (-0.01%)
OMGA : 2.40 (-0.83%)
SANA : 7.70 (-0.39%)
MCRB : 0.5765 (-1.32%)
Flagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development Officer PR Newswire - Mon Sep 11, 2023

/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, announced today the appointment of Amanda Kay as Senior Partner and Chief Business...

DNLI : 16.20 (-2.41%)
FHTX : 5.61 (+1.45%)
MRNA : 101.99 (-0.01%)
OMGA : 2.40 (-0.83%)
SANA : 7.70 (-0.39%)
MCRB : 0.5765 (-1.32%)
Flagship Pioneering Announces Appointment of David Khougazian as Growth Partner PR Newswire - Tue Aug 29, 2023

/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, announced today that pharma and healthcare leader David Khougazian is joining as...

DNLI : 16.20 (-2.41%)
FHTX : 5.61 (+1.45%)
MRNA : 101.99 (-0.01%)
OMGA : 2.40 (-0.83%)
SANA : 7.70 (-0.39%)
MCRB : 0.5765 (-1.32%)
Flagship Pioneering Appoints Jason Gardner as CEO-Partner and CEO of Ampersand Biomedicines PR Newswire - Mon Aug 14, 2023

/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, and Ampersand Biomedicines, a company programming smarter medicines that act...

DNLI : 16.20 (-2.41%)
FHTX : 5.61 (+1.45%)
MRNA : 101.99 (-0.01%)
OMGA : 2.40 (-0.83%)
SANA : 7.70 (-0.39%)
MCRB : 0.5765 (-1.32%)
Seres Therapeutics: Q2 Earnings Snapshot AP - Tue Aug 8, 2023

Seres Therapeutics: Q2 Earnings Snapshot

MCRB : 0.5765 (-1.32%)
Seres Therapeutics (MCRB) Reports Q1 Loss, Misses Revenue Estimates Zacks - Tue May 9, 2023

Seres Therapeutics (MCRB) delivered earnings and revenue surprises of 0% and 126.10%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

MCRB : 0.5765 (-1.32%)
SRNEQ : 0.0300 (+3.45%)
Seres Therapeutics: Q1 Earnings Snapshot AP - Tue May 9, 2023

Seres Therapeutics: Q1 Earnings Snapshot

MCRB : 0.5765 (-1.32%)

Barchart Exclusives

Netflix Stock Tumbles on Huge Gain in FCF - Shorting OTM Puts for Income Makes Sense Here Barchart - 7 minutes ago
Netflix stock is down about 8% after releasing excellent earnings yesterday. This makes no sense despite market concerns about its reporting. Shorting OTM puts is attractive for income and a cheaper buy-in. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot